1977-2019
FUNDING AMOUNT104136605 USD
ABSTRACTThe mission of the Comprehensive Cancer Center at St. Jude Children's Research Hospital (SJCCC) is to advance cures and means of prevention for pediatric cancer: the leading cause of disease-related death in children aged 1 to 14 years. For 36 of our 50 year history, we have pursued this mission with the support of a Cancer Center Support Grant from the National Cancer Institute (NCI). We remain the only NCI designated Cancer Center that is dedicated solely to the research and treatment of pediatric malignancies. As such, we serve as a national and international resource for health care providers, children with cancer, and their families. Through the support of the American Lebanese and Syrian Associated Charities (ALSAC), a separate corporation whose sole purpose is to raise money in support of St. Jude Children's Research Hospital (SJCRH), patients are accepted without regard to race, religion or ability to pay. Seventy-five percent of the total institutional space and annual budget are invested in the SJCCC. The current application proposes five multidisciplinary research Programs that are organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects: our three disease-oriented Programs focus on Developmental Biology and Solid Tumors (DBSTP), Hematological Malignancies (HMP), and Neurobiology and Brain Tumors (NBTP); our Cancer Prevention and Control Program (CPCP) strives to improve the quality of life of individuals surviving childhood cancer; and our new Cancer Genetics, Biochemistry and Cell Biology Program (CGBCBP), formed by merging our two prior basic laboratory research Programs, embeds basic cancer research within the heart of the SJCCC, facilitating direct interaction between the disease-oriented Programs and the major laboratory resources in the Center. Research by the 144 aligned members is supported by 10 Shared Resources and an outstanding clinical research infrastructure. During the previous funding period, a new Director was appointed and several enhancements were made to the overall structure, policies, and procedures of the SJCCC. 32,522 clinical trial enrollments occurred at the Center during the current funding period, of which 56% were to SJCCC investigator initiated studies. External peer reviewed trials, many which are SJCCC member-led, accounted for another 38% of enrollments. SJCCC members published more than 2,100 manuscripts during the funding period, and in the last 12 months were supported by $69.4 million in extramural funding ($57 million, peer-reviewed; $12.4 million, non-peer-reviewed). More... »
URLhttp://projectreporter.nih.gov/project_info_description.cfm?aid=9439706
http://scigraph.springernature.com/grant.2438833
DIMENSIONShttps://app.dimensions.ai/details/grant/grant.2438833
NIHP30CA021765
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"type": "DefinedTerm"
}
],
"amount": {
"currency": "USD",
"type": "MonetaryAmount",
"value": "104136605"
},
"description": "The mission of the Comprehensive Cancer Center at St. Jude Children's Research Hospital (SJCCC) is to advance cures and means of prevention for pediatric cancer: the leading cause of disease-related death in children aged 1 to 14 years. For 36 of our 50 year history, we have pursued this mission with the support of a Cancer Center Support Grant from the National Cancer Institute (NCI). We remain the only NCI designated Cancer Center that is dedicated solely to the research and treatment of pediatric malignancies. As such, we serve as a national and international resource for health care providers, children with cancer, and their families. Through the support of the American Lebanese and Syrian Associated Charities (ALSAC), a separate corporation whose sole purpose is to raise money in support of St. Jude Children's Research Hospital (SJCRH), patients are accepted without regard to race, religion or ability to pay. Seventy-five percent of the total institutional space and annual budget are invested in the SJCCC. The current application proposes five multidisciplinary research Programs that are organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects: our three disease-oriented Programs focus on Developmental Biology and Solid Tumors (DBSTP), Hematological Malignancies (HMP), and Neurobiology and Brain Tumors (NBTP); our Cancer Prevention and Control Program (CPCP) strives to improve the quality of life of individuals surviving childhood cancer; and our new Cancer Genetics, Biochemistry and Cell Biology Program (CGBCBP), formed by merging our two prior basic laboratory research Programs, embeds basic cancer research within the heart of the SJCCC, facilitating direct interaction between the disease-oriented Programs and the major laboratory resources in the Center. Research by the 144 aligned members is supported by 10 Shared Resources and an outstanding clinical research infrastructure. During the previous funding period, a new Director was appointed and several enhancements were made to the overall structure, policies, and procedures of the SJCCC. 32,522 clinical trial enrollments occurred at the Center during the current funding period, of which 56% were to SJCCC investigator initiated studies. External peer reviewed trials, many which are SJCCC member-led, accounted for another 38% of enrollments. SJCCC members published more than 2,100 manuscripts during the funding period, and in the last 12 months were supported by $69.4 million in extramural funding ($57 million, peer-reviewed; $12.4 million, non-peer-reviewed).",
"endDate": "2019-02-28T00:00:00Z",
"funder": {
"id": "https://www.grid.ac/institutes/grid.48336.3a",
"type": "Organization"
},
"id": "sg:grant.2438833",
"identifier": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"2438833"
]
},
{
"name": "nih_id",
"type": "PropertyValue",
"value": [
"P30CA021765"
]
}
],
"inLanguage": [
"en"
],
"keywords": [
"Cell Biology Program",
"cancer",
"cancer prevention",
"research",
"years",
"international resources",
"major laboratory resources",
"race",
"prevention",
"DBSTP",
"long-term side effects",
"procedure",
"comprehensive cancer center",
"children",
"SJCCC investigator",
"biochemistry",
"heart",
"NBTP",
"pediatric cancer",
"HMP",
"means",
"St. Jude Children's Research Hospital",
"enrollment",
"basic cancer research",
"CCSG",
"trials",
"control programs",
"new Cancer Genetics",
"family",
"current funding period",
"religion",
"external peers",
"months",
"Syrian Associated Charities",
"ALSAC",
"developmental biology",
"aligned members",
"National Cancer Institute",
"money",
"peer",
"death",
"CPCP",
"percent",
"cause",
"hematological malignancies",
"pediatric malignancies",
"funding period",
"basic science discoveries",
"individuals",
"outstanding clinical research infrastructure",
"Shared Resources",
"treatment",
"SJCCC members",
"center",
"overall structure",
"quality",
"extramural funding",
"cure",
"cancer center",
"previous funding period",
"year history",
"prior basic laboratory research Programs",
"Solid Tumors",
"sole purpose",
"current applications",
"new director",
"several enhancements",
"annual budget",
"mission",
"childhood cancer",
"multidisciplinary research program",
"specific intent",
"clinical trial enrollment",
"life",
"support",
"disease",
"patients",
"Cancer Center Support Grant",
"curative therapy",
"health care providers",
"total institutional space",
"only NCI",
"ability",
"direct interaction",
"manuscript",
"separate corporation",
"Programs",
"neurobiology",
"CGBCBP",
"SJCCC",
"study",
"policy",
"regard",
"Brain Tumors"
],
"name": "Cancer Center Support Grant Year 35 (CCSG)",
"recipient": [
{
"id": "https://www.grid.ac/institutes/grid.240871.8",
"type": "Organization"
},
{
"affiliation": {
"id": "https://www.grid.ac/institutes/grid.240871.8",
"name": "ST. JUDE CHILDREN'S RESEARCH HOSPITAL",
"type": "Organization"
},
"familyName": "ROBERTS",
"givenName": "CHARLES",
"id": "sg:person.012404741132.65",
"type": "Person"
},
{
"member": "sg:person.012404741132.65",
"roleName": "PI",
"type": "Role"
}
],
"sameAs": [
"https://app.dimensions.ai/details/grant/grant.2438833"
],
"sdDataset": "grants",
"sdDatePublished": "2019-03-07T12:11",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz",
"startDate": "1977-09-01T00:00:00Z",
"type": "MonetaryGrant",
"url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9439706"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438833'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438833'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438833'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438833'
This table displays all metadata directly associated to this object as RDF triples.
138 TRIPLES
19 PREDICATES
116 URIs
108 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:grant.2438833 | schema:about | anzsrc-for:2211 |
2 | ″ | schema:amount | Ncba47bfe487f4f86a8bd99d7bd8d4863 |
3 | ″ | schema:description | The mission of the Comprehensive Cancer Center at St. Jude Children's Research Hospital (SJCCC) is to advance cures and means of prevention for pediatric cancer: the leading cause of disease-related death in children aged 1 to 14 years. For 36 of our 50 year history, we have pursued this mission with the support of a Cancer Center Support Grant from the National Cancer Institute (NCI). We remain the only NCI designated Cancer Center that is dedicated solely to the research and treatment of pediatric malignancies. As such, we serve as a national and international resource for health care providers, children with cancer, and their families. Through the support of the American Lebanese and Syrian Associated Charities (ALSAC), a separate corporation whose sole purpose is to raise money in support of St. Jude Children's Research Hospital (SJCRH), patients are accepted without regard to race, religion or ability to pay. Seventy-five percent of the total institutional space and annual budget are invested in the SJCCC. The current application proposes five multidisciplinary research Programs that are organized with the specific intent of translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects: our three disease-oriented Programs focus on Developmental Biology and Solid Tumors (DBSTP), Hematological Malignancies (HMP), and Neurobiology and Brain Tumors (NBTP); our Cancer Prevention and Control Program (CPCP) strives to improve the quality of life of individuals surviving childhood cancer; and our new Cancer Genetics, Biochemistry and Cell Biology Program (CGBCBP), formed by merging our two prior basic laboratory research Programs, embeds basic cancer research within the heart of the SJCCC, facilitating direct interaction between the disease-oriented Programs and the major laboratory resources in the Center. Research by the 144 aligned members is supported by 10 Shared Resources and an outstanding clinical research infrastructure. During the previous funding period, a new Director was appointed and several enhancements were made to the overall structure, policies, and procedures of the SJCCC. 32,522 clinical trial enrollments occurred at the Center during the current funding period, of which 56% were to SJCCC investigator initiated studies. External peer reviewed trials, many which are SJCCC member-led, accounted for another 38% of enrollments. SJCCC members published more than 2,100 manuscripts during the funding period, and in the last 12 months were supported by $69.4 million in extramural funding ($57 million, peer-reviewed; $12.4 million, non-peer-reviewed). |
4 | ″ | schema:endDate | 2019-02-28T00:00:00Z |
5 | ″ | schema:funder | https://www.grid.ac/institutes/grid.48336.3a |
6 | ″ | schema:identifier | Nae05d6af6786401e8e3663eef1c01653 |
7 | ″ | ″ | Ncf7c091d5d244dfbbda1b27693092fea |
8 | ″ | schema:inLanguage | en |
9 | ″ | schema:keywords | ALSAC |
10 | ″ | ″ | Brain Tumors |
11 | ″ | ″ | CCSG |
12 | ″ | ″ | CGBCBP |
13 | ″ | ″ | CPCP |
14 | ″ | ″ | Cancer Center Support Grant |
15 | ″ | ″ | Cell Biology Program |
16 | ″ | ″ | DBSTP |
17 | ″ | ″ | HMP |
18 | ″ | ″ | NBTP |
19 | ″ | ″ | National Cancer Institute |
20 | ″ | ″ | Programs |
21 | ″ | ″ | SJCCC |
22 | ″ | ″ | SJCCC investigator |
23 | ″ | ″ | SJCCC members |
24 | ″ | ″ | Shared Resources |
25 | ″ | ″ | Solid Tumors |
26 | ″ | ″ | St. Jude Children's Research Hospital |
27 | ″ | ″ | Syrian Associated Charities |
28 | ″ | ″ | ability |
29 | ″ | ″ | aligned members |
30 | ″ | ″ | annual budget |
31 | ″ | ″ | basic cancer research |
32 | ″ | ″ | basic science discoveries |
33 | ″ | ″ | biochemistry |
34 | ″ | ″ | cancer |
35 | ″ | ″ | cancer center |
36 | ″ | ″ | cancer prevention |
37 | ″ | ″ | cause |
38 | ″ | ″ | center |
39 | ″ | ″ | childhood cancer |
40 | ″ | ″ | children |
41 | ″ | ″ | clinical trial enrollment |
42 | ″ | ″ | comprehensive cancer center |
43 | ″ | ″ | control programs |
44 | ″ | ″ | curative therapy |
45 | ″ | ″ | cure |
46 | ″ | ″ | current applications |
47 | ″ | ″ | current funding period |
48 | ″ | ″ | death |
49 | ″ | ″ | developmental biology |
50 | ″ | ″ | direct interaction |
51 | ″ | ″ | disease |
52 | ″ | ″ | enrollment |
53 | ″ | ″ | external peers |
54 | ″ | ″ | extramural funding |
55 | ″ | ″ | family |
56 | ″ | ″ | funding period |
57 | ″ | ″ | health care providers |
58 | ″ | ″ | heart |
59 | ″ | ″ | hematological malignancies |
60 | ″ | ″ | individuals |
61 | ″ | ″ | international resources |
62 | ″ | ″ | life |
63 | ″ | ″ | long-term side effects |
64 | ″ | ″ | major laboratory resources |
65 | ″ | ″ | manuscript |
66 | ″ | ″ | means |
67 | ″ | ″ | mission |
68 | ″ | ″ | money |
69 | ″ | ″ | months |
70 | ″ | ″ | multidisciplinary research program |
71 | ″ | ″ | neurobiology |
72 | ″ | ″ | new Cancer Genetics |
73 | ″ | ″ | new director |
74 | ″ | ″ | only NCI |
75 | ″ | ″ | outstanding clinical research infrastructure |
76 | ″ | ″ | overall structure |
77 | ″ | ″ | patients |
78 | ″ | ″ | pediatric cancer |
79 | ″ | ″ | pediatric malignancies |
80 | ″ | ″ | peer |
81 | ″ | ″ | percent |
82 | ″ | ″ | policy |
83 | ″ | ″ | prevention |
84 | ″ | ″ | previous funding period |
85 | ″ | ″ | prior basic laboratory research Programs |
86 | ″ | ″ | procedure |
87 | ″ | ″ | quality |
88 | ″ | ″ | race |
89 | ″ | ″ | regard |
90 | ″ | ″ | religion |
91 | ″ | ″ | research |
92 | ″ | ″ | separate corporation |
93 | ″ | ″ | several enhancements |
94 | ″ | ″ | sole purpose |
95 | ″ | ″ | specific intent |
96 | ″ | ″ | study |
97 | ″ | ″ | support |
98 | ″ | ″ | total institutional space |
99 | ″ | ″ | treatment |
100 | ″ | ″ | trials |
101 | ″ | ″ | year history |
102 | ″ | ″ | years |
103 | ″ | schema:name | Cancer Center Support Grant Year 35 (CCSG) |
104 | ″ | schema:recipient | Nf7c365f7ad8f4eb4800785482df581e1 |
105 | ″ | ″ | sg:person.012404741132.65 |
106 | ″ | ″ | https://www.grid.ac/institutes/grid.240871.8 |
107 | ″ | schema:sameAs | https://app.dimensions.ai/details/grant/grant.2438833 |
108 | ″ | schema:sdDatePublished | 2019-03-07T12:11 |
109 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
110 | ″ | schema:sdPublisher | N092aa56d3c7e4e05b04e55e41e962417 |
111 | ″ | schema:startDate | 1977-09-01T00:00:00Z |
112 | ″ | schema:url | http://projectreporter.nih.gov/project_info_description.cfm?aid=9439706 |
113 | ″ | sgo:license | sg:explorer/license/ |
114 | ″ | sgo:sdDataset | grants |
115 | ″ | rdf:type | schema:MonetaryGrant |
116 | N092aa56d3c7e4e05b04e55e41e962417 | schema:name | Springer Nature - SN SciGraph project |
117 | ″ | rdf:type | schema:Organization |
118 | Nae05d6af6786401e8e3663eef1c01653 | schema:name | dimensions_id |
119 | ″ | schema:value | 2438833 |
120 | ″ | rdf:type | schema:PropertyValue |
121 | Ncba47bfe487f4f86a8bd99d7bd8d4863 | schema:currency | USD |
122 | ″ | schema:value | 104136605 |
123 | ″ | rdf:type | schema:MonetaryAmount |
124 | Ncf7c091d5d244dfbbda1b27693092fea | schema:name | nih_id |
125 | ″ | schema:value | P30CA021765 |
126 | ″ | rdf:type | schema:PropertyValue |
127 | Nf7c365f7ad8f4eb4800785482df581e1 | schema:member | sg:person.012404741132.65 |
128 | ″ | schema:roleName | PI |
129 | ″ | rdf:type | schema:Role |
130 | anzsrc-for:2211 | schema:inDefinedTermSet | anzsrc-for: |
131 | ″ | rdf:type | schema:DefinedTerm |
132 | sg:person.012404741132.65 | schema:affiliation | https://www.grid.ac/institutes/grid.240871.8 |
133 | ″ | schema:familyName | ROBERTS |
134 | ″ | schema:givenName | CHARLES |
135 | ″ | rdf:type | schema:Person |
136 | https://www.grid.ac/institutes/grid.240871.8 | schema:name | ST. JUDE CHILDREN'S RESEARCH HOSPITAL |
137 | ″ | rdf:type | schema:Organization |
138 | https://www.grid.ac/institutes/grid.48336.3a | ″ | schema:Organization |